enVVeno Medical (NVNO)

The company’s initial product candidate, the VenoValve, is designed as a surgical replacement venous valve. Building on that platform, enVVeno is focused on the enVVe System, a next-generation product intended to offer a less invasive treatment option. The system includes the enVVe Valve along with the delivery device, nose cone, accessories, and crimping system needed to place the valve through a catheter-based procedure.

This approach is intended to reduce the need for open surgery by delivering a bioprosthetic venous valve through minimally invasive techniques. If successful, the technology could address a group of patients with limited treatment alternatives, particularly those whose disease is not adequately managed by compression therapy, wound care, or other existing interventions.

enVVeno operates as a single medical device development business in the United States. Like many development-stage healthcare companies, its value is closely tied to product progress, clinical evidence, regulatory pathways, manufacturing readiness, and the potential commercial market for its devices. The company is distinctive for concentrating on venous valve replacement, a niche but medically significant area within vascular care.